Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Enveric's EB-003 Shows Positive Preclinical Results for PTSD Treatment
Enveric Biosciences highlights positive preclinical data for EB-003 in PTSD models, showing rapid reduction in fear response without hallucinogenic effects.
BeOne Signs $2B Deal for Preclinical Trispecific Antibody from Huahui
BeOne Medicines pays $20M upfront for an option to buy Huahui Health's preclinical trispecific antibody HH160, with potential milestones up to $1.9B.
FDA Authorizes Early Access to Daraxonrasib for Pancreatic Cancer Care
The US FDA authorizes an early access program for Revolution Medicines' daraxonrasib (RMC-6236) for patients with previously treated pancreatic cancer.
FDA Approves Vepdegestrant for ESR1-Mutant Advanced Breast Cancer Therapy
The FDA has approved vepdegestrant (ARV-471), the first PROTAC degrader, for patients with ESR1-mutated advanced breast cancer based on VERITAC-2 data.
UCB Data at AAN 2026 Highlights Psychosocial Impacts of Epilepsy on Life
UCB presents new data highlighting the profound impact of epilepsy, sleep disruption, and prolonged seizures on patients and caregivers at AAN 2026.
Phase 3 Trial of Synthetic Hypericin for CTCL Halted Early for Futility
Soligenix's Phase 3 FLASH2 trial of synthetic hypericin for cutaneous T-cell lymphoma (CTCL) stopped for futility. Read full details and prior trial data.
FDA Approves AstraZeneca's Breztri Aerosphere for Asthma Maintenance
The FDA has approved AstraZeneca's Breztri Aerosphere, the first single-inhaler triple therapy for the maintenance treatment of asthma in the US.
Addex Therapeutics Reveals Promising Preclinical Data for Chronic Cough
Addex Therapeutics shares promising preclinical data for ADX71441, an allosteric modulator showing significant effects against IPF-related chronic cough.
Genexine's SOX2 Degrader GX-BP1 Demonstrates Up to 96% TGI in Study
Genexine presents preclinical data for SOX2-targeting bioPROTAC GX-BP1 at AACR 2026, showing up to 96% tumor growth inhibition and preventing tumor relapse.
AI-Designed Drug Cuts Fentanyl Intake in New Preclinical OUD Study
A new AI-designed compound significantly reduces fentanyl intake and alters brain circuits in a preclinical rat model, offering hope for opioid use disorder.
Arcera and Fosun Pharma Sign Strategic MoU for Neuroscience Innovation
Arcera Life Sciences and Fosun Pharma signed a strategic MoU to accelerate global neuroscience innovation and expand patient access to breakthrough therapies.
Sanofi Gains EU CHMP Endorsement for Tolebrutinib to Treat MS
Europe’s CHMP recommends Sanofi’s tolebrutinib for secondary progressive multiple sclerosis, marking a significant win after previous regulatory setbacks.
1
2
3
4
5
6
7
